Since we showed that expression of AKR1B1 from tumor stroma was associated with favorable prognosis via IHC, while bulk transcriptomic data suggested the opposite pattern in certain cohorts, we hypothesized that tumor purity may affect clinical outcomes based on AKR1B1 expression. Here, AKR1B1 is linked to neoplasm.